| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 75 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 75 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 75 |
| 3 | LENALIDOMIDE | 57 |
| 4 | DEXAMETHASONE | 47 |
| 5 | DEXAMETHASONE 1.5 MG | 47 |
| 6 | ETOPOSIDE | 37 |
| 7 | RITUXIMAB | 33 |
| 8 | PREDNISONE | 30 |
| 9 | DOXORUBICIN | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOGUANINE | 10 | 0.0047 |
| 1 | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0047 |
| 2 | IBRITUMOMAB TIUXETAN | 7 | 0.0046 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 14 | 0.0022 |
| 4 | OXACILLIN SODIUM | 2 | 0.0018 |
| 5 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 6 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 7 | CARMUSTINE | 5 | 0.0011 |
| 8 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 9 | MELPHALAN HYDROCHLORIDE | 26 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 90 |
| 1 | Alkylating Drug [EPC] | 88 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 67 |
| 3 | Thalidomide Analog [EPC] | 57 |
| 4 | Topoisomerase Inhibitor [EPC] | 37 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 6 | Platinum-based Drug [EPC] | 26 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 8 | Proteasome Inhibitor [EPC] | 19 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 37 | 0.0005 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 2 | Alkylating Drug [EPC] | 88 | 0.0004 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 67 | 0.0002 |
| 6 | Iron Chelator [EPC] | 5 | 0.0002 |
| 7 | Proteasome Inhibitor [EPC] | 19 | 0.0002 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 15 | 0.0001 |